Valuation: Samsung Biologics Co.,Ltd.

Capitalization 90,128B 61.16B 52.72B 49.08B 45.69B 85.08B 5,549B 91.54B 565B 223B 2,647B 229B 225B 9,665B P/E ratio 2025 *
58.7x
P/E ratio 2026 * 48.3x
Enterprise value 88.8B 60.26M 51.95M 48.36M 45.02M 83.83M 5.47B 90.19M 556M 219M 2.61B 226M 221M 9.52B EV / Sales 2025 *
15.5x
EV / Sales 2026 * 14.1x
Free-Float
25.44%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.92%
1 week+94.70%
Current month+94.70%
1 month+94.70%
3 months+94.70%
6 months+94.70%
Current year+94.70%
More quotes
1 week 1,000,000
Extreme 999999.9999
1,981,000
1 month 1,000,000
Extreme 999999.9999
1,981,000
Current year 1,000,000
Extreme 999999.9999
1,981,000
1 year 1,000,000
Extreme 999999.9999
1,981,000
3 years 1,000,000
Extreme 999999.9999
1,981,000
5 years 1,000,000
Extreme 999999.9999
1,981,000
10 years 192,960.76
Extreme 192960.7607
1,981,000
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 09/12/2020
Director of Finance/CFO 58 14/03/2025
Investor Relations Contact 59 01/01/2014
Director TitleAgeSince
Chairman 64 09/12/2020
Director/Board Member 72 29/03/2022
Director/Board Member 67 20/03/2020
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.92%+94.70%+94.70%+94.70% 61.96B
-1.20%-7.97%+5.74%+0.68% 76.12B
+2.35%+5.19%+39.57%+233.17% 57.24B
+0.14%+0.62%-36.48%-37.97% 56.7B
-2.46%-11.60%+16.61%-42.92% 24.73B
+0.92%+0.27%+46.58%+31.40% 20.66B
+0.56%+0.56%+167.56%+112.34% 19.8B
+10.10%+8.25%+70.68%+1,369.50% 17.14B
+6.28%+23.54%+20.30%-78.21% 15.38B
0.00%+3.31%+117.89%+771.54% 14.7B
Average +1.58%+1.91%+54.32%+245.42% 36.44B
Weighted average by Cap. +0.64%+0.34%+39.65%+144.16%
See all sector performances

Financials

2025 *2026 *
Net sales 5,722B 3.88B 3.35B 3.12B 2.9B 5.4B 352B 5.81B 35.84B 14.13B 168B 14.56B 14.26B 614B 6,223B 4.22B 3.64B 3.39B 3.16B 5.87B 383B 6.32B 38.98B 15.37B 183B 15.84B 15.51B 667B
Net income 1,634B 1.11B 956M 890M 828M 1.54B 101B 1.66B 10.24B 4.04B 47.99B 4.16B 4.07B 175B 1,899B 1.29B 1.11B 1.03B 963M 1.79B 117B 1.93B 11.9B 4.69B 55.77B 4.83B 4.73B 204B
Net Debt -1,325B -899M -775M -722M -672M -1.25B -81.59B -1.35B -8.3B -3.27B -38.92B -3.37B -3.3B -142B -2,588B -1.76B -1.51B -1.41B -1.31B -2.44B -159B -2.63B -16.21B -6.39B -76B -6.58B -6.45B -277B
More financial data * Estimated data
Logo Samsung Biologics Co.,Ltd.
Samsung Biologics Co Ltd is a Korea-based company primarily engaged in the production of antibody drugs. The Company operates through two segments. The Contract Development and Manufacturing Organization (CDMO) segment primarily provides biopharmaceutical contract manufacturing and cell line development services. The Biopharmaceutical Development and Commercialization segment primarily engages in the development and commercialization of biosimilars.
Employees
4,770
More about the company
Date Price Change Volume
16/01/26 1,947,000.00 -0.92% 68,134
15/01/26 1,965,000.00 +1.97% 70,485
14/01/26 1,927,000.00 +1.00% 86,681
13/01/26 1,908,000.00 +2.64% 77,125
12/01/26 1,859,000.00 -1.01% 68,736

End-of-day quote Korea S.E., January 16, 2026

More quotes
Trader
Investor
Global
Quality
ESG MSCI
BBB
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
1,947,000.00KRW
Average target price
2,249,248.65KRW
Spread / Average Target
+15.52%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A207940 Stock